After the Wilkinson Stekloff team, led by Sean Eskovitz, Alex Walsh, James Rosenthal, and Kieran Gostin, won a decisive victory for Bayer in a $600 million certified consumer class action lawsuit brought on behalf of One A Day multivitamin consumers, Litigation Daily‘s Jenna Greene wrote about how Eskovitz and Walsh were “so good” at the cross-examinations that “the Wilkinson Stekloff team called no defense witnesses. They annihilated the case on crosses alone”:
If cross-examination is an art form, then Wilkinson Stekloff name partners Alexandra Walsh and Sean Eskovitz (pictured above) are masters.
The duo led a trial team defending Bayer AG, which faced a $600 million certified consumer class action over its One A Day multivitamin. The plaintiffs alleged Bayer made false and misleading claims that One A Day supported heart health, immunity and physical energy.
How good were the cross-examinations? So good that that the Wilkinson Stekloff team called no defense witnesses. They annihilated the case on crosses alone.
After a week-long trial, a federal jury in San Francisco on Feb. 22 took just an hour to find for the defense across the board.
It’s a little like slowing down to look at a car crash, but through the magic of trial transcripts, let’s see how they shredded two key witnesses.
The full article can be found here.